Article Text

Download PDFPDF
Journal club
Nicotine replacement therapy in pregnancy
  1. Thomas D Stringfellow,
  2. John D Blakey
  1. Correspondence to Dr John D Blakey, Clinical Lecturer, Respiratory Medicine, Clinical Sciences Building, City Hospital Campus, Nottingham NG5 1PB, UK; john.blakey{at}nottingham.ac.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Cigarette smoking is a major modifiable cause of adverse pregnancy outcomes. Nicotine-replacement therapy (NRT) is recommended in guidelines, but its efficacy and safety during pregnancy is uncertain.

This multicentre double-blind trial recruited 1050 pregnant participants who were in their 12–24 weeks' gestation periods. All of them smoked ≥5 cigarettes per day (median 20). Participants were randomly assigned …

View Full Text